IVIATIn Vivo Induced Antigen Technology
References in periodicals archive ?
Oragenics' research in the field of probiotic oral care has led to a pipeline of products ranging from novel anti-infectives to this IVIAT platform technology.
Oragenics' scientists also plan to further utilize its patented IVIAT platform technology to discover unique gene targets for a number of other serious and dangerous human infectious diseases.
IVIAT can quickly and easily identify in vivo induced genes in human infections without the use of animal models, facilitating the discovery of new targets for the development of vaccines, antimicrobials and diagnostics.